Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Genitourinary 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Other 1Lymphoid 1Gastrointestinal 1Classical hematology 1CNS 1Breast 1

Conditions

Mucositis 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 678Cytarabine 576fludarabine 410fludarabine phosphate 387venetoclax 310Methotrexate 297Rituximab 283Azacitidine 265Busulfan 248Whole-Body Irradiation 220Etoposide 215Filgrastim 214Peripheral Blood Stem Cell Transplantation 211Mycophenolic Acid 206Tacrolimus 196Dexamethasone 191Granulocyte Colony-Stimulating Factor 182Vincristine 173Melphalan 173Decitabine 163Cyclosporine 146Daunorubicin 139Antilymphocyte Serum 137Idarubicin 134Imatinib Mesylate 127Lenalidomide 116Doxorubicin 109Radiotherapy 108Stem Cell Transplantation 107Clofarabine 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Quercetin × Other hematologic neoplasm × Clear all
NCT01732393 2012-12-05

Effect of Quercetin in Prevention and Treatment of Oral Mucositis

Mashhad University of Medical Sciences

Phase 1/2 Completed
20 enrolled
OtherOther hematologic neoplasm

Hematologic Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡